Panion & BF Biotech Inc - Asset Resilience Ratio

Latest as of September 2023: -0.52%

Panion & BF Biotech Inc (1760) has an Asset Resilience Ratio of -0.52% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Panion & BF Biotech Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

NT$-16.14 Million
≈ $-508.47K USD Cash + Short-term Investments

Total Assets

NT$3.08 Billion
≈ $97.00 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2009–2021)

This chart shows how Panion & BF Biotech Inc's Asset Resilience Ratio has changed over time. See Panion & BF Biotech Inc (1760) balance sheet quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Panion & BF Biotech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Panion & BF Biotech Inc market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$-16.14 Million -0.52%
Total Liquid Assets NT$-16.14 Million -0.52%

Asset Resilience Insights

  • Limited Liquidity: Panion & BF Biotech Inc maintains only -0.52% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Panion & BF Biotech Inc Industry Peers by Asset Resilience Ratio

Compare Panion & BF Biotech Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 0.00%
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
Biotechnology -55.36%
Krystal Biotech Inc
NASDAQ:KRYS
Biotechnology 23.06%
Verona Pharma PLC ADR
NASDAQ:VRNA
Biotechnology 0.00%
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA
Biotechnology 33.37%
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
Biotechnology 8.08%
Hebei Changshan Biochem Pharma
SHE:300255
Biotechnology -0.03%
BB Biotech AG
SW:BION
Biotechnology 0.05%

Annual Asset Resilience Ratio for Panion & BF Biotech Inc (2009–2021)

The table below shows the annual Asset Resilience Ratio data for Panion & BF Biotech Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2021-12-31 2.36% NT$69.79 Million
≈ $2.20 Million
NT$2.95 Billion
≈ $93.04 Million
-0.76pp
2020-12-31 3.13% NT$96.13 Million
≈ $3.03 Million
NT$3.07 Billion
≈ $96.85 Million
-2.12pp
2019-12-31 5.25% NT$100.32 Million
≈ $3.16 Million
NT$1.91 Billion
≈ $60.25 Million
+1.39pp
2018-12-31 3.86% NT$70.74 Million
≈ $2.23 Million
NT$1.83 Billion
≈ $57.81 Million
+2.53pp
2017-12-31 1.32% NT$16.49 Million
≈ $519.40K
NT$1.25 Billion
≈ $39.30 Million
-0.49pp
2016-12-31 1.81% NT$21.59 Million
≈ $680.14K
NT$1.19 Billion
≈ $37.53 Million
-0.25pp
2015-12-31 2.06% NT$24.24 Million
≈ $763.69K
NT$1.18 Billion
≈ $37.03 Million
-0.22pp
2014-12-31 2.28% NT$25.25 Million
≈ $795.54K
NT$1.11 Billion
≈ $34.91 Million
+1.37pp
2013-12-31 0.91% NT$9.10 Million
≈ $286.70K
NT$1.00 Billion
≈ $31.52 Million
-0.60pp
2012-12-31 1.51% NT$13.96 Million
≈ $439.69K
NT$924.20 Million
≈ $29.12 Million
-0.06pp
2011-12-31 1.58% NT$14.71 Million
≈ $463.51K
NT$934.09 Million
≈ $29.43 Million
+0.72pp
2010-12-31 0.86% NT$7.41 Million
≈ $233.46K
NT$861.72 Million
≈ $27.15 Million
-0.74pp
2009-12-31 1.60% NT$14.00 Million
≈ $441.20K
NT$873.43 Million
≈ $27.52 Million
--
pp = percentage points

About Panion & BF Biotech Inc

TW:1760 Taiwan Biotechnology
Market Cap
$161.80 Million
NT$5.14 Billion TWD
Market Cap Rank
#17462 Global
#902 in Taiwan
Share Price
NT$59.90
Change (1 day)
+0.50%
52-Week Range
NT$58.80 - NT$73.40
All Time High
NT$228.22
About

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment,… Read more